click below
click below
Normal Size Small Size show me how
CNS 2-3
BDK list
| Term | Definition |
|---|---|
| Focalin, Focalin XR | dexmethylphenidate |
| Focalin (dexmethylphenidate) indication is | ADHD |
| The pharmacologic category for dexmethylphenidate is | CNS stimulant |
| The classification of dexmethylphenidate is | CS II |
| Adderall, Adderall XR | dextroamphetamine and amphetamine |
| Adderall (dextroamphetamine and amphetamine) indication is | ADHD, narcolepsy |
| The pharmacologic category for dextroamphetamine and amphetamine is | CNS stimulant |
| The classification of dextroamphetamine and amphetamine is | CS II |
| Vyvanse | lisdexamfetamine |
| Vyvanse (lisdexamfetamine) indication is | ADHD |
| The pharmacologic category for lisdexamfetamine is | CNS stimulant |
| The classification of lisdexamfetamine is | CS II |
| Concerta, Ritilin, Daytrana (patch) | methylphenidate |
| Concerta (methylphenidate) indication is | ADHD, narcolepsy |
| The pharmacologic category for methylphenidate is | CNS stimulant |
| The classification of methylphenidate is | CS II |
| Intuniv | guanfacine |
| Intuniv (guanfacine) indication is | ADHD, HTN |
| The pharmacologic category for guanfacine is | selective alpha 2 agonist |
| Mirapex | pramipexole |
| Mirapex (pramipexole) indication is | parkinson's disease, RLS |
| The pharmacologic category for pramipexole is | dopamine agonist |
| Requip | ropinirole |
| Requip (ropinirole) indication is | parkinson's disease, RLS |
| The pharmacologic category for ropinirole is | dopamine agonist |
| Sinemet, CR | carbidopa and levodopa |
| Sinemet (carbidopa and levodopa) indication is | parkinson's disease |
| The pharmacologic category for carbidopa levodopa is | decarboxylase inhibitor |
| Namenda | memantine |
| Namenda (memantine) indication is | dementia |
| The pharmacologic category for memantine is | N-methyl-D-aspartate antagonist (NMDA) |
| Aricept | donepizil |
| Aricept (donepezil) indication is | dementia |
| The pharmacologic category for donepezil is | cholinesterase inhibitor |
| Lithobid | lithium |
| Lithobid (lithium) indication is | bipolar disorder |
| The pharmacologic category for lithium is | antimanic agent |
| Imitrex | sumatriptan |
| Imitrex (sumatriptan) indication is | migraine |
| The pharmacologic category for sumatriptan is | antimigraine |
| Maxalt | rizatriptan |
| Maxalt (rizatriptan) indication is | migraine |
| The pharmacologic category for rizatriptan is | antimigraine |
| Haldol | haloperidol |
| Haldol (haloperidol) indication is | schizophrenia |
| The pharmacologic category for haloperidol is | first-generation antisychotic |
| Clozaril | clozapine |
| Clozaril (clozapine) indication is | treatment resistant antipsychotic |
| The pharmacologic category for clozapine is | second-generation antisychotic |
| Abilify | aripriprazole |
| Abilify (aripiprazole) indication is | Schizophrenia, bipolar disorder, MDD |
| The pharmacologic category for aripiprazole is | second-generation antipsychotic |
| Seroquel | queitiapine |
| Seroquel (quetiapine) indication is | Schizophrenia, bipolar disorder, MDD |
| The pharmacologic category for quetiapine is | second -generation antipsychotic |
| Latuda | lurasidone |
| Latuda (lurasidone) indication is | Schizophrenia, bipolar disorder, MDD |
| The pharmacologic category for lurasidone is | second-generation antipsychotic |
| Zyprexa | olanzapine |
| Zyprexa (olanzapine) indication is | Schizophrenia, bipolar disorder, MDD |
| The pharmacologic category for olanzapine is | second-generation antipsychotic |
| Risperdal | risperidone |
| Risperdal (risperidone) indication is | Schizophrenia, bipolar disorder, MDD |
| The pharmacologic category for risperidone is | second-generation antipsychotic |